Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Morfini

Showing results (41-50 of 151) with videos related to

Pageof 16
Sort By:
Transfusion|October 1, 1993
Prospective study of the evaluation of hepatitis C virus infectivity in a high-purity, solvent/detergent-treated factor VIII concentrate: parallel evaluation of other markers for lipid-enveloped and non-lipid-enveloped viruses. The Ad Hoc Study Group of the Fondazione dell'EmofiliaG Mariani, T Di Paolantonio, R Baklaya, et al.
The Knee|July 3, 2007
A modular total knee arthroplasty in haemophilic arthropathyM Innocenti, R Civinini, C Carulli, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|June 21, 2013
Are the standard definitions of osteopenia and osteoporosis appropriate for coinfected patients with haemophilia?S Linari, G Montorzi, M Borderi, et al.
American Journal of Hematology|March 1, 1992
Human parvovirus B19 infection in hemophiliacs first infused with two high-purity, virally attenuated factor VIII concentratesA Azzi, S Ciappi, K Zakvrzewska, et al.
Journal of Thrombosis and Haemostasis : JTH|November 25, 2003
A multicenter pharmacokinetic study of the B-domain deleted recombinant factor VIII concentrate using different assays and standardsM Morfini, S Cinotti, A Bellatreccia, et al.
Thrombosis and Haemostasis|November 1, 2001
Relationship between factor VII activity and clinical efficacy of recombinant factor VIIa given by continuous infusion to patients with factor VIII inhibitorsE Santagostino, M Morfini, A Rocino, et al.
Thrombosis and Haemostasis|April 1, 1993
Two novel mutations at 373 codon of FVIII gene detected by DGGEM Acquila, D Caprino, M Pecorara, et al.
Journal of Thrombosis and Haemostasis : JTH|May 16, 2018
Pharmacokinetics and the transition to extended half-life factor concentrates: communication from the SSC of the ISTHM V Ragni, S E Croteau, M Morfini, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|March 8, 2002
Single-dose pharmacokinetics of porcine factor VIII (Hyate C)C Hermans, D Owens, P Lilley, et al.
British Journal of Haematology|July 1, 1992
Human parvovirus B19 in clotting factor concentrates: B19 DNA detection by the nested polymerase chain reactionK Zakrzewska, A Azzi, G Patou, et al.
Pageof 16

Showing results (41-50 of 151) with videos related to

Sort By:
Pageof 16
Transfusion|October 1, 1993
Prospective study of the evaluation of hepatitis C virus infectivity in a high-purity, solvent/detergent-treated factor VIII concentrate: parallel evaluation of other markers for lipid-enveloped and non-lipid-enveloped viruses. The Ad Hoc Study Group of the Fondazione dell'EmofiliaG Mariani, T Di Paolantonio, R Baklaya, et al.
The Knee|July 3, 2007
A modular total knee arthroplasty in haemophilic arthropathyM Innocenti, R Civinini, C Carulli, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|June 21, 2013
Are the standard definitions of osteopenia and osteoporosis appropriate for coinfected patients with haemophilia?S Linari, G Montorzi, M Borderi, et al.
American Journal of Hematology|March 1, 1992
Human parvovirus B19 infection in hemophiliacs first infused with two high-purity, virally attenuated factor VIII concentratesA Azzi, S Ciappi, K Zakvrzewska, et al.
Journal of Thrombosis and Haemostasis : JTH|November 25, 2003
A multicenter pharmacokinetic study of the B-domain deleted recombinant factor VIII concentrate using different assays and standardsM Morfini, S Cinotti, A Bellatreccia, et al.
Thrombosis and Haemostasis|November 1, 2001
Relationship between factor VII activity and clinical efficacy of recombinant factor VIIa given by continuous infusion to patients with factor VIII inhibitorsE Santagostino, M Morfini, A Rocino, et al.
Thrombosis and Haemostasis|April 1, 1993
Two novel mutations at 373 codon of FVIII gene detected by DGGEM Acquila, D Caprino, M Pecorara, et al.
Journal of Thrombosis and Haemostasis : JTH|May 16, 2018
Pharmacokinetics and the transition to extended half-life factor concentrates: communication from the SSC of the ISTHM V Ragni, S E Croteau, M Morfini, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|March 8, 2002
Single-dose pharmacokinetics of porcine factor VIII (Hyate C)C Hermans, D Owens, P Lilley, et al.
British Journal of Haematology|July 1, 1992
Human parvovirus B19 in clotting factor concentrates: B19 DNA detection by the nested polymerase chain reactionK Zakrzewska, A Azzi, G Patou, et al.
Pageof 16